Using Dried Blood Spots to Quantitatively Detect Anti–SARS-CoV-2 IgG Antibodies by ELISA: A Validation Study
The American Journal of Tropical Medicine and Hygiene · 2024
DOI: 10.4269/ajtmh.23-0306 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, 2024. Verfasst von Michelle Ylade und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Child Health and Human Development, National Institutes of Health, University of the Philippines-Manila, Manila, Philippines. Hauptthemen laut MEDLINE: Immunoglobulin G, SARS-CoV-2, Antibodies, Viral, Enzyme-Linked Immunosorbent Assay. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
SARS-CoV-2 serological testing is useful to determine seroprevalence, epidemiological trends, and the extent of transmission. The collection and transport of serum samples can be logistically challenging, especially in remote underserved areas. Dried blood spots (DBSs) would allow easier sample collection and logistical handling compared with standard serum collection, particularly for extensive and repeated SARS-CoV-2 serosurveys. We evaluated the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the IgG ELISA (Wantai, Beijing, China) using DBSs against sera for the quantitative detection of SARS-CoV-2 IgG antibody. The IgG ELISA was used to test paired sera and DBSs obtained from individuals with recent virologically confirmed COVID-19 illness and banked paired sera and DBSs collected before the COVID-19 pandemic. We found that 100/100 (100%) seropositive samples were positive using DBSs, and 193/194 (99%) seronegative samples were negative using DBSs. Compared with sera, the DBS method had a 100% sensitivity, 99% specificity, 99% PPV, and 100% NPV. Use of DBSs for SARS-CoV-2 household or population serosurveys may be considered in situations with limitations in sample collection, shipment, and storage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Child Health and Human Development, National Institutes of Health, University of the Philippines-Manila, Manila, Philippines.
- International Vaccine Institute, Seoul, Korea.
- Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, United Kingdom.
- Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany.
- Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar.
- Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
Zitieren
APA
Ylade, M., Aziz, A. B., Daag, J. V., Crisostomo, M. V., Agrupis, K. A., Maronilla, M. A., Sye Lim Hong, C., Kim, H. Y., Njau, I., Lopez, M. H. J., Deen, J., Kim, D. R., You, Y. A., Kang, S. S. Y., Marks, F., & Tadesse, B. T. (2024). Using Dried Blood Spots to Quantitatively Detect Anti–SARS-CoV-2 IgG Antibodies by ELISA: A Validation Study. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.23-0306
Vancouver
Ylade M, Aziz AB, Daag JV, Crisostomo MV, Agrupis KA, Maronilla MA, et al. Using Dried Blood Spots to Quantitatively Detect Anti–SARS-CoV-2 IgG Antibodies by ELISA: A Validation Study. The American Journal of Tropical Medicine and Hygiene. 2024. doi:10.4269/ajtmh.23-0306
BibTeX
@article{Ylade2024,
author = {Ylade, Michelle and Aziz, Asma Binte and Daag, Jedas Veronica and Crisostomo, Maria Vinna and Agrupis, Kristal-An and Maronilla, Maria Angela and Sye Lim Hong, Chloe and Kim, Hwa Young and Njau, Irene and Lopez, March Helena Jane and Deen, Jacqueline and Kim, Deok Ryun and You, Young Ae and Kang, Sophie S Y and Marks, Florian and Tadesse, Birkneh Tilahun},
title = {Using Dried Blood Spots to Quantitatively Detect Anti–SARS-CoV-2 IgG Antibodies by ELISA: A Validation Study},
journal = {The American Journal of Tropical Medicine and Hygiene},
year = {2024},
doi = {10.4269/ajtmh.23-0306}
}
EUVIMED